No products in the cart.
Rexigo 120 mg (Relugolix)
Rexigo 120 mg contains Relugolix, a daily oral GnRH antagonist used for testosterone suppression in advanced prostate cancer treatment.
Rexigo 120 mg (Relugolix)
| Active Ingredient | Relugolix |
|---|---|
| Indication: | Advanced prostate cancer |
| Manufacturer: | Zydus Lifesciences |
| Packaging | 10 Tablet PR in 1 strip |
| Strength | 120mg |
| Delivery Time | 6 To 15 days |
Rexigo 120mg contains Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of advanced prostate cancer. It works by reducing the production of testosterone, a hormone that fuels the growth of prostate cancer cells. Unlike traditional injectable therapies, Relugolix is an oral tablet, offering a convenient, non-invasive option for hormone suppression therapy.
Rexigo 120 mg is typically given as a starting (loading) dose, followed by a daily maintenance dose (usually 40 mg) as part of a long-term treatment plan. It is designed to rapidly lower testosterone levels without the initial hormone surge that injectable GnRH agonists may cause.
| pack size | 30 Tablets – USD $3.78 Per Tablet, 60 Tablets – USD $3.60 Per Tablet, 90 Tablets – USD $3.40 Per Tablet |
|---|
Be the first to review “Rexigo 120 mg (Relugolix)”
You must be logged in to post a review.
Related Products
Buy Veenat 100 Capsule (Imatinib)
Price range: $64.00 through $195.00
Buy Flonida Cream 1% (Fluorouracil)
Price range: $8.00 through $30.00
Buy Anabrez 1Mg (Anastrozole)
Price range: $50.00 through $145.00
Buy Veenat 400 Mg (Imatinib)
Price range: $255.00 through $810.00
There are no reviews yet.